136 related articles for article (PubMed ID: 22406086)
1. Treatment of BK viremia in a pediatric heart transplant recipient.
Butts RJ; Uber WE; Savage AJ
J Heart Lung Transplant; 2012 May; 31(5):552-3. PubMed ID: 22406086
[No Abstract] [Full Text] [Related]
2. Combination of Leflunomide and Everolimus for treatment of BK virus nephropathy.
Jaw J; Hill P; Goodman D
Nephrology (Carlton); 2017 Apr; 22(4):326-329. PubMed ID: 28247521
[TBL] [Abstract][Full Text] [Related]
3. BK virus nephritis after renal transplantation.
Hariharan S
Kidney Int; 2006 Feb; 69(4):655-62. PubMed ID: 16395271
[TBL] [Abstract][Full Text] [Related]
4. Stabilization of renal function after the first year of follow-up in kidney transplant recipients treated for significant BK polyomavirus infection or BK polyomavirus-associated nephropathy.
Simard-Meilleur MC; Bodson-Clermont P; St-Louis G; Pâquet MR; Girardin C; Fortin MC; Cardinal H; Hébert MJ; Lévesque R; Renoult E
Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28207975
[TBL] [Abstract][Full Text] [Related]
5. [BK virus infections in pediatric kidney transplant recipients].
Mutlu D; Sağlık I; Koyun M; Comak E; Mutlu E; Uslu Gökçeoğlu A; Cağla Doğan S; Dinçkan A; Akbaş SH; Akkaya B; Akman S; Süleymanlar G; Colak D
Mikrobiyol Bul; 2013 Jul; 47(3):461-71. PubMed ID: 23971923
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Intravenous Immunoglobulin in the Treatment of Persistent BK Viremia and BK Virus Nephropathy in Renal Transplant Recipients.
Shah T; Vu D; Naraghi R; Campbell A; Min D
Clin Transpl; 2014; ():109-16. PubMed ID: 26281134
[TBL] [Abstract][Full Text] [Related]
7. Leflunomide efficacy and pharmacodynamics for the treatment of BK viral infection.
Krisl JC; Taber DJ; Pilch N; Chavin K; Bratton C; Thomas B; McGillicuddy J; Baliga P
Clin J Am Soc Nephrol; 2012 Jun; 7(6):1003-9. PubMed ID: 22461534
[TBL] [Abstract][Full Text] [Related]
8. Leflunomide for polyomavirus type BK nephropathy.
Williams JW; Javaid B; Kadambi PV; Gillen D; Harland R; Thistlewaite JR; Garfinkel M; Foster P; Atwood W; Millis JM; Meehan SM; Josephson MA
N Engl J Med; 2005 Mar; 352(11):1157-8. PubMed ID: 15784677
[No Abstract] [Full Text] [Related]
9. Concurrent antiviral and immunosuppressive activities of leflunomide in vivo.
Chong AS; Zeng H; Knight DA; Shen J; Meister GT; Williams JW; Waldman WJ
Am J Transplant; 2006 Jan; 6(1):69-75. PubMed ID: 16433758
[TBL] [Abstract][Full Text] [Related]
10. Leflunomide treatment for polyomavirus BK-associated nephropathy after kidney transplantation.
Faguer S; Hirsch HH; Kamar N; Guilbeau-Frugier C; Ribes D; Guitard J; Esposito L; Cointault O; Modesto A; Lavit M; Mengelle C; Rostaing L
Transpl Int; 2007 Nov; 20(11):962-9. PubMed ID: 17666021
[TBL] [Abstract][Full Text] [Related]
11. Leflunomide therapy in kidney transplantation: ready for prime time?
Mannon RB
Clin J Am Soc Nephrol; 2008 May; 3(3):652-3. PubMed ID: 18385395
[No Abstract] [Full Text] [Related]
12. Contrasting patterns of viral load response in transplant recipients with BK polyomavirus DNAemia on leflunomide therapy.
Cuellar-Rodriguez J; Stephany B; Poggio E; Mossad SB; Goldfarb D; Lard M; Askar M; Fatica R; Srinivas T; Braun W; Shoskes D; Flechner S; Schmitt SK; Shrestha R; Avery RK
Clin Transplant; 2013; 27(3):E230-6. PubMed ID: 23551281
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of and Risk Factors for BK Polyomavirus Replication and Nephropathy in Pediatric Renal Transplant Recipients: An International CERTAIN Registry Study.
Höcker B; Schneble L; Murer L; Carraro A; Pape L; Kranz B; Oh J; Zirngibl M; Dello Strologo L; Büscher A; Weber LT; Awan A; Pohl M; Bald M; Printza N; Rusai K; Peruzzi L; Topaloglu R; Fichtner A; Krupka K; Köster L; Bruckner T; Schnitzler P; Hirsch HH; Tönshoff B
Transplantation; 2019 Jun; 103(6):1224-1233. PubMed ID: 30130322
[TBL] [Abstract][Full Text] [Related]
14. Conversion from tacrolimus-mycophenolate mofetil to tacrolimus-mTOR immunosuppression after kidney-pancreas transplantation reduces the incidence of both BK and CMV viremia.
Knight RJ; Graviss EA; Nguyen DT; Kuten SA; Patel SJ; Gaber L; Gaber AO
Clin Transplant; 2018 Jun; 32(6):e13265. PubMed ID: 29676018
[TBL] [Abstract][Full Text] [Related]
15. Leflunomide therapy for BK virus allograft nephropathy after pediatric kidney transplantation.
Jung YH; Moon KC; Ha JW; Kim SJ; Ha IS; Cheong HI; Kang HG
Pediatr Transplant; 2013 Mar; 17(2):E50-4. PubMed ID: 23210794
[TBL] [Abstract][Full Text] [Related]
16. In kidney transplant recipients with BK polyomavirus infection, early BK nephropathy, microvascular inflammation, and serum creatinine are risk factors for graft loss.
Mohamed M; Parajuli S; Muth B; Astor BC; Panzer SE; Mandelbrot D; Zhong W; Djamali A
Transpl Infect Dis; 2016 Jun; 18(3):361-71. PubMed ID: 26998753
[TBL] [Abstract][Full Text] [Related]
17. Higher levels of leflunomide are associated with hemolysis and are not superior to lower levels for BK virus clearance in renal transplant patients.
Leca N; Muczynski KA; Jefferson JA; de Boer IH; Kowalewska J; Kendrick EA; Pichler R; Davis CL
Clin J Am Soc Nephrol; 2008 May; 3(3):829-35. PubMed ID: 18372319
[TBL] [Abstract][Full Text] [Related]
18. Leflunomide therapy for polyomavirus-induced allograft nephropathy: efficient BK virus elimination without increased risk of rejection.
Teschner S; Gerke P; Geyer M; Wilpert J; Krumme B; Benzing T; Walz G
Transplant Proc; 2009; 41(6):2533-8. PubMed ID: 19715969
[TBL] [Abstract][Full Text] [Related]
19. Clinical utility of leflunomide for BK polyomavirus associated nephropathy in kidney transplant recipients: A multicenter retrospective study.
Keller N; Duquennoy S; Conrad A; Fafi-Kremer S; Morelon E; Bouvier N; Moulin B; Hurault De Ligny B; Caillard S
Transpl Infect Dis; 2019 Apr; 21(2):e13058. PubMed ID: 30730102
[TBL] [Abstract][Full Text] [Related]
20. A novel treatment regimen for BK viremia.
Zaman RA; Ettenger RB; Cheam H; Malekzadeh MH; Tsai EW
Transplantation; 2014 Jun; 97(11):1166-71. PubMed ID: 24531848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
